Type 2 & other diabetes

Estimating the economic burden of diabetes in young adults: A global analysis based on the GBD 2021 and a value of statistical life year framework

Diabet MedPublished Economic burden analysis based on the Global Burden of Disease Study 2021

Authors' conclusion

Diabetes in young adults represents a significant and growing macroeconomic burden. Our findings underscore the urgent need for public health strategies and economic policies focused on preventing type 2 diabetes. Such interventions are especially critical for countries with fragile health systems to mitigate substantial future economic and health losses.

Study context

Population
Individuals aged 15–39 years with diabetes, global, regional and national
Outcome
Value of lost welfare (VLW) from monetized disability-adjusted life-years (DALYs)
Follow-up
2021; projections to 2050
Methodological detailsvalue of a statistical life year approach, projections to 2050
  • Value of a statistical life year approach
  • Projections to 2050

Main finding

As reported in the abstract

Global economic burden (VLW) · 2021

Global economic burden

Int$1.16 trillion

Low-SDI regions: highest relative burden (% of GDP)

1.21%

East Asia: highest absolute burden

Int$240.30 billion

Oceania: highest relative impact (% of GDP)

3.03%

Further findings

Projected burden · 2050

Burden will more than double by 2050, driven almost entirely by T2D (% of global GDP)
1.32%

Original publication

Estimating the economic burden of diabetes in young adults: A global analysis based on the GBD 2021 and a value of statistical life year framework. Diabet Med. Published 13 February 2026. doi:10.1111/dme.70255

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.